FIELD: pharmacology.
SUBSTANCE: invention relates to pharmaceutical composition for sensory nerve suppression, being sensitive to capsaicine, for therapy of interstitial cystitis, disturbance in lower urinary tract, and abacterial prostatitis. Claimed composition contains quinuclidine-3'-yl-1-phenyl-1,2,34-tetrahydroisoquinoline-2-carboxylate having increased effectiveness.
EFFECT: composition for treatment of interstitial cystitis having increased effectiveness.
5 cl, 1 dwg, 2 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| 3,4-DIHYDROBENZOXAZINE COMPOUNDS AND VANILLOID RECEPTOR SUBTYPE 1 (VR1) INHIBITORS | 2006 |
|
RU2427579C2 |
| AQUEOUS COMPOSITION FOR INSTILLATION IN BLADDER | 2015 |
|
RU2586285C1 |
| NEW DERIVATIVES OF QUINUCLIDINE AND MEDICINAL COMPOSITIONS CONTAINING THEREOF | 1995 |
|
RU2143432C1 |
| THERAPEUTIC AGENT FOR TREATING LOWER URINARY TRACT DISEASE AND AGENT FOR IMPROVING LOWER URINARY TRACT SYMPTOM | 2009 |
|
RU2527679C2 |
| METHOD FOR TREATMENT OF PAIN OR INTERSTITIAL CYSTITIS, USING INDOLE COMPOUND | 2019 |
|
RU2791025C2 |
| APPLICATION OF ANTAGONISTS OF METABOTROPIC GLUTAMATE RECEPTORS (mGLuR5), ESPECIALLY AFQ056, FOR TREATMENT OF GASTROINTESTINAL TRACT (GIT), ESPECIALLY GASTROESOPHAGEAL REFLUX (GER) | 2006 |
|
RU2422138C2 |
| PHENOXYALKYL CARBONIC ACIDS DERIVATIVE IN TREATMENT OF INFLAMMATORY DISEASES | 2005 |
|
RU2388466C2 |
| METHOD FOR TREATMENT AND PREVENTION OF CYSTITIS | 2020 |
|
RU2751649C1 |
| BENZAMIDE DERIVATIVES OR PHARMACEUTICALLY ACCEPTABLE SALTS OF SAID DERIVATIVES, PHARMACEUTICAL COMPOSITION BASED THERE ON AND APPLICATION THEREOF | 2004 |
|
RU2333198C2 |
| PREPARATIONS OF THERMO-ABRASIVE HYDROGEL FOR APPLICATION IN TREATMENT OF UTERTAL DISORDERS | 2013 |
|
RU2635466C2 |
